Evaluation of a 10color protocol as part of a 2tube screening panel for flow cytometric assessment of peripheral blood leukocytic subsets

References

• Béné MC, Le Bris Y, Robillard N. Flow cytometry in hematologic nonmalignant disorders. Int J Lab Hematol. 2016;38(1):5–16.
   PubMed Web of Science ®Google Scholar
• Davis BH, Holden JT, Béné MC, et al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom. 2007;72 S1:S5–S13.
   Google Scholar
• Guy J, Wagner-Ballon O, Pages O, et al. A 5-color flow cytometric method for extended 8-part leukocyte differential. Cytometry B Clin Cytom. 2017;92(6):498–507.
   PubMed Web of Science ®Google Scholar
• Faucher JL, Lacronique-Gazaille C, Frébet E, et al. “6 Markers/5 colors” extended white blood cell differential by flow cytometry. Cytometry. 2007;71(11):934–944.
   PubMedGoogle Scholar
• Roussel M, Davis BH, Fest T, et al. Toward a reference method for leukocyte differential counts in blood: comparison of three flow cytometric candidate methods. Cytometry. 2012;81:973–982.
   PubMedGoogle Scholar
• Björnsson S, Wahlström S, Norström E, et al. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer. Cytometry. 2008;74(2):91–103.
   PubMedGoogle Scholar
• Cherian S, Levin G, Lo WY, et al. Evaluation of an 8-color flow cytometric reference method for white blood cell differential enumeration. Cytometry B Clin Cytom. 2010;78(5):319–928.
   PubMedGoogle Scholar
• Hedley BD, Keeney M, Popma J, et al. Novel lymphocyte screening tube using dried monoclonal antibody reagents. Cytometry. 2015;88B:361–370.
   Google Scholar
• Kim AH, Lee W, Kim M, et al. White blood cell differential counts in severely leukopenic samples: a comparative analysis of different solutions available in modern laboratory hematology. Blood Res. 2014;49(2):120–126.
   PubMedGoogle Scholar
• Williams-Voorbeijtel D, Sanchez F, Roth CG. Aligning the flow cytometric evaluation with the diagnostic need: an evidence-based approach. J Clin Pathol. 2017;70(9):740–744.
   PubMed Web of Science ®Google Scholar
• van de Geijn GJ, van Rees V, van Pul-Bom N. Leukoflow: multiparameter extended white blood cell differentiation for routine analysis by flow cytometry. Cytometry. 2011;79 A:694–706.
   Google Scholar
• Van Dongen JJM, Lhermitte L, Böttcher S, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26(9):1908–1975.
   PubMed Web of Science ®Google Scholar
• Rajab A, Axler O, Leung J, et al. Ten-color 15-antibody flow cytometry panel for immunophenotyping of lymphocyte population. Int J Lab Hematol. 2017;39:76–85.
   PubMed Web of Science ®Google Scholar
• van der Velden VHJ, Flores-Montero J, Perez-Andres M, et al. Optimization and testing of dried antibody tube: the EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;pii: S0022–1759(17):30095–9.
   Google Scholar
• Streitz M, Miloud T, Kapinsky M, et al. Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplant Res. 2013;2(1):17.
   PubMedGoogle Scholar
• Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood. 2015;126(4):454–462.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2017; p. 585.
   Google Scholar
• Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8(10):1640–1645.
   PubMed Web of Science ®Google Scholar
• Rawstron AC, Kreuzer KA, Soosapilla A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry. 2018;94B:121–128.
   Google Scholar
• Ortolani C. Flow cytometry of hematological malignancies. Chichester: Wiley-Blackwell; 2011; p. 311.
   Google Scholar
• Correia RP, Rajab A, Bento LC, et al. A ten-color tube with dried antibody reagents for the screening of hematological malignancies. Int J Lab Hematol. 2018;40(2):136–143.
   PubMed Web of Science ®Google Scholar
• Selimoglu-Buet D, Wagner-Ballon O, Saada V, et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood. 2015;125(23):3618–3626.
   PubMed Web of Science ®Google Scholar
• Serke S, Van Lessen A, Hummel M, et al. Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma. Cytometry. 2000;42(3):180–187.
   PubMedGoogle Scholar
• Lefèvre G, Copin MC, Staumont-Sallé D, et al. The lymphoid variant of hypereosinophilic syndrome study of 21 patients with CD3-CD4+ aberrant T-cell phenotype. Medicine (Baltimore). 2014;93(17):255–266.
   PubMed Web of Science ®Google Scholar
• Morice WG. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. Am J Clin Pathol. 2007;127(6):881–886.
   PubMed Web of Science ®Google Scholar
• Lima M, Almeida J, Dos Anjos Teixeira M, et al. TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. Am J Pathol. 2003;163(2):763–771.
   PubMed Web of Science ®Google Scholar
• Porwit A. Immunophenotyping of selected hematologic disorders – focus on lymphoproliferative disorders with more than one malignant cell population. Int J Lab Hematol. 2013;35(3):275–282.
   PubMed Web of Science ®Google Scholar
• Melzer S, Zachariae S, Bocsi J, et al. Reference intervals for leukocyte subsets in adults: results from a population-based study using 10-color flow cytometry. Cytometry. 2015;88:270–281.
   PubMedGoogle Scholar
• Park SH, Park BG, Park CJ, et al. An extended leukocyte differential count (16 types of circulating leukocytes) using the cytodiff flow cytometric system can provide information for the discrimination of sepsis severity and prediction of outcome in sepsis patients. Cytometry. 2014;86:244–256.
   PubMedGoogle Scholar
• Allou K, Vial JP, Béné MC, et al. The routine leukocyte differential flow cytometry HematoFlowTM method: a new flagging system for automatic validation. Cytometry. 2015;88:375–384.
   PubMedGoogle Scholar
• Kverneland AH, Streitz M, Geissler E, et al. Age and gender leucocytes variances and references values generated using the standardized ONE-Study protocol. Cytometry. 2016;89:543–564.
   PubMedGoogle Scholar
• Porwit A, Béné MC. Multiparameter flow cytometry in the diagnosis of hematologic malignancies. Cambridge: Cambridge University Press; 2018; p. 234.
   Google Scholar
• Béné MC, Nebe T, Bettelheim P, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia. 2011;25(4):567–574.
   PubMed Web of Science ®Google Scholar
• Orvain C, Luque Paz D, Dobo I, et al. Circulating CD34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study. Ann Hematol. 2016;95(11):1819–1823.
   PubMed Web of Science ®Google Scholar
• Zeng H, Yin L-D, Li P, et al. The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors. Hematology. 2016;21(9):513.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Sato S, Koyamatsu J, et al. Platelets and circulating CD34-positive cells as an indicator of the activity of the vicious cycle between hypertension and endothelial dysfunction in elderly Japanese men. Atherosclerosis. 2017;259:26–31.
   PubMed Web of Science ®Google Scholar
• Ginaldi L, De Martinis M, Matutes E, et al. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol. 1998;51(5):364–369.
   PubMed Web of Science ®Google Scholar
• Almasri NM, Duque RE, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol. 1992;40(4):259–263.
   PubMed Web of Science ®Google Scholar
• Monaghan SA, Peterson LC, James C, et al. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL). Cytometry B Clin Cytom. 2003;56(1):30–42.
   PubMedGoogle Scholar
• Moreau EJ, Matutes E, A’Hern RP, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol. 1997;108(4):378–382.
   PubMed Web of Science ®Google Scholar
• Carulli G, Cannizzo E, Zucca A, et al. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas. Leuk Res. 2008;32(2):263–267.
   PubMed Web of Science ®Google Scholar
• Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111(8):3941–3967.
   PubMed Web of Science ®Google Scholar